Case Report: Severe psoriasis skin lesions following ofatumumab treatment for multiple sclerosis
The article explores a case study of a patient diagnosed with relapsing-remitting multiple sclerosis (RRMS) who, while receiving treatment with the anti-CD20 monoclonal antibody ofatumumab, developed psoriatic skin lesions. Initially, sharply demarcate…